Literature DB >> 9387326

[Double cancers: a clinical analysis of 156 cases].

W Li1, Y Zhan, G Li.   

Abstract

In order to study the causes of multiple primary carcinomas (MPC), and to give proper treatment, 156 patients with double cancers were analyzed retrospectively. The patients were admitted to the hospital from 1982 to 1987, accounting 0.47% of all hospitalized patients with malignant tumors in the same period. Out of them 86 patients were male, 70 patients were female. The age ranged from 17 to 80 old-year, the median 50 old-year. In 34 cases, the two cancers were synchronous in occurrence while in 122 cases were metachronous. The nasopharynx, lungs, large bowel and mammary gland were the most common sites of the MPC. The principle of treatment of the MPC was the same as that for ordinary primary carcinoma. The total 5-year survival rate was 34.6%.

Entities:  

Mesh:

Year:  1996        PMID: 9387326

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  4 in total

1.  Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in female patients with breast cancer or genitalia malignancies.

Authors:  Li Xiao; Tiantian Cao; Jiali Ou; Weijiang Liang
Journal:  PeerJ       Date:  2022-06-24       Impact factor: 3.061

2.  Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors.

Authors:  Meng Lv; Xiao Zhang; Yanwei Shen; Fan Wang; Jiao Yang; Biyuan Wang; Zheling Chen; Pan Li; Xiaoman Zhang; Shuting Li; Jin Yang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

3.  Double primary bronchogenic carcinoma of the lung and papillary thyroid carcinoma: a case report.

Authors:  Jen-Hsun Cheng; Ying-Chieh Huang; Chih Kuo; Yih-Shyong Lai; Tzu-Ching Wu; Thomas Chang-Yao Tsao; Shi-Ping Luh; Chong-Bin Tsai
Journal:  J Med Case Rep       Date:  2008-09-23

4.  Clinical features and prognosis of duplex primary malignant neoplasms involving chronic myeloid leukemia.

Authors:  Chunshui Liu; Cong Wang; Zhonghua Du; Hongwei Xue; Zhihe Liu
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.